Media Coverage Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 Search YAHOO FINANCE AACR 2024 Annual Meeting-Visit Senhwa Biosciences Exhibit Booth Apr 03 2024 PR Newswire Senhwa Biosciences Announces First Patient Successfully Dosed in Taiwan Phase II Study of Silmitasertib in Hospitalized Adults with COVID-19 Nov 09 2023 PR Newswire Senhwa Biosciences Announces IND Submission to US FDA for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection Oct 19 2023 Bloomberg Senhwa Biosciences Announces Successful Awardee of Anticancer Pipeline, Pidnarulex, in NIH-Sponsored NExT Program Dec 01 2022 PR Newswire At the 2022 AAD Annual Meeting, Senhwa Presents Positive Initial Data from Clinical Trial of Silmitasertib Used to Treat Patients with Advanced Basal Cell Carcinoma Mar 28 2022 Yahoo Finance Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer Jan 20 2022 PR Newswire Senhwa’s Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma Dec 17 2021 Yahoo Finance Senhwa Clinical Data Abstract for Silmitasertib in Patients with Advanced Basal Cell Carcinoma Accepted for 2022 AAD Annual Meeting Dec 16 2021 1 2 3 4 5